LINCOLN
Lincoln Pharma notched 42% higher Q4 EPS of Rs 6.3 and 21% higher FY21 EPS of Rs 31 is the cheapest pharma share. With likely EPS of Rs 38, the share trades at a forward P/E of 9x.
Lincoln Pharma has entered the fast track. The Company is now debt free and has aggressive expansion programs. Rising exports and strong financials make this share a good buy. Will be a great buy near 315-320 levels.
Lincoln Pharma has entered the fast track. The Company is now debt free and has aggressive expansion programs. Rising exports and strong financials make this share a good buy. Will be a great buy near 315-320 levels.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.